Elamex SA (ELAMF) Fair Value & Analysis

Consumer Defensive · US · Market cap $7.5M

A solid business, screening 138% undervalued on our models.

What matters now

• The price is below even our cautious bear case ($4.07). The market is more pessimistic than our downside scenario.
• Solid quality (53/100) at a price below fair value, the discount is the argument here, not the business quality.
• A fairly wide model range ($4.07 to $9.31) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.

How to read this chart

60‑month range $2.00 – $10.40 · fair‑value band $4.07 – $9.31 · the $2.81 price screens below the $6.69 fair value. Dashed = 300-day average. As of Jul 24, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Elamex SA (ELAMF) currently trades at $2.81, while our model-based Fair Value estimate is $6.69, implying the stock looks roughly 138.1% undervalued today. The Quality Score stands at 53/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Elamex SA generated revenue of $111M at a net margin of -0.4%. Revenue grew 9.0% year over year. It earns a return on equity of -1.7%. Net debt stands at $10.1M. Fundamentals as of Jul 24, 2026

Our scenario range runs from $4.07 (bear case) to $9.31 (bull case); at $2.81, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 1% below its 52-week high and 31% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 138%, ELAMF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Multiples ($8.08) versus Growth DCF ($5.67). Highest evidence: Growth DCF (80).

Key figures & financial health

Quality Score breakdown

About the company

Elamex SA de CV engages in candy manufacturing, and nut processing and packaging in the United States and Mexico. It produces sugar candies, such as starlight mints, orange slices, spice drops, jelly beans, and gummies.

Full company description

Elamex SA de CV engages in candy manufacturing, and nut processing and packaging in the United States and Mexico. It produces sugar candies, such as starlight mints, orange slices, spice drops, jelly beans, and gummies. The company also processes packaged nuts, including pecans, walnuts, and almonds; and bulk foodservice items, such as sunflower seeds and trail mixes. In addition, it offers contract manufacturing services for food products; and warehousing and logistics services. Further, the company engages in real estate holdings in Mexico. It sells sugar candies through grocery, drug, mass merchant, food service, and convenience channels; and markets and distributes packaged nuts to foodservice and retail markets. The company serves restaurants, healthcare facilities, hotels, schools, and colleges. Elamex SA de CV was founded in 1973 and is headquartered in El Paso, Texas. It has operations in Mexico and the United States. The company has a distribution center in El Paso, Texas.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2002 – FY2006 · reported fiscal years

Elamex SA reported revenue of $105M in FY2006 versus $134M in FY2002, a compound −6.0%/yr. Reported net income was −$2.3M in FY2006.

Watch ELAMF: get an alert when its fair value changes →

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Packaged Foods median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.